Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
about
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart diseaseThe role of natriuretic peptides for the diagnosis of left ventricular dysfunctionSpectrum bias--why clinicians need to be cautious when applying diagnostic test studiesN-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul studyNatriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care.Natriuretic Peptide testing in primary careNatriuretic peptides in the detection of preclinical diastolic or systolic dysfunction.Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewNatriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons.Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trialsMeta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population.Brain natriuretic peptide in the contemporary management of congestive heart failure.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.The prognostic value of N-terminal proB-type natriuretic peptide.The role of erythropoietin in myocardial protection: potential mechanisms and applications.Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.Utility of N terminal pro brain natriuretic peptide in elderly patientsThe ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-proBNP measurement.Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.Natriuretic peptide testing in primary care patients.The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure.Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis.N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)Unmet needs in managing hypertension: potential role of direct renin inhibition.Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule.Heart failure biomarkers.Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.High-density lipoprotein is superior to B-type natriuretic peptide as a marker of systolic dysfunction in an elderly general population.Accuracy of a heart failure diagnosis in administrative registers.Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure.Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
P2860
Q24607043-C778C8D5-4058-4CCC-9896-F78799970F72Q26825665-98AA519F-C054-4ADE-88FF-4F4256BD17B7Q28292809-6EED1F9A-59B5-4C2B-BA25-F4EB8D78580FQ31105305-0F1AA7C4-18E9-44E3-B1EF-F68D434E3ED0Q33321054-D1492869-0B58-4211-9DAC-B9D5C2EC620DQ33572286-C3BEEA0A-1527-420E-8C48-B0D4EEA72638Q33743581-BAC22744-C01E-414B-95A8-D8C3605262DCQ33848664-3C831139-9F53-4624-B7E2-BC24808A63CBQ33932889-41CFF89D-3BF0-4836-B8AE-95012F511418Q33948944-1B5A4B7D-B3F2-47F4-AE89-F560E450F9BCQ34614873-0C8203D6-71AB-4111-B07C-821D9C501BADQ34753074-DA604472-734B-4663-A74F-1482477453EBQ35216649-F6E5E356-7E4D-476B-9F14-0569A13E4653Q36014317-4AB1E3DB-5D98-4031-B4E7-B4AD34B41131Q36050481-7A28F70D-A27C-4711-BA68-DBDAABA3D89FQ36124913-BA867D78-2FFE-40EC-88AE-649865951ED3Q36304293-DFECCCD8-B3C5-40BD-B3B4-0F6AA94103F1Q36352011-DD071341-CC97-4DDC-9F7E-9397AB805DFFQ36433506-520CF658-2F1A-489F-9B2B-BEA8817841A6Q36716456-E0EBF99A-EA31-4128-B31B-6390DB9307E9Q36928221-27F523A0-4400-48D5-8027-DA6F1F944010Q36944131-AD84AE9D-902B-4343-9F2C-004564136DC6Q37036751-A516AF8E-3D62-4FB5-BA61-CEB82F23E394Q37078080-DDE1F621-7AE2-4DAA-AF84-D4B86C1CE502Q37097127-99C8C635-21E1-4006-B7E6-1734D509FBAAQ37108057-49F9F666-CBF0-4920-89E1-B7796685009AQ37291305-D9C01B17-4E3D-4B97-9F29-6DA87013789FQ37301554-BC284F66-7C01-4C4D-B4A1-9A009505C172Q37313438-32271209-06C1-4E6D-9E7D-253E94820FBBQ37658795-5A394BBE-7DF0-4B00-8599-374CA5D3D475Q37750291-987F7C7C-3857-46A9-B385-CEC774781669Q38020022-869D0C95-BF64-4B50-91F0-97055EA650F1Q38100647-94025BFA-5924-4698-9923-E2921D2437CEQ40640730-41FF962F-01A4-45E5-BBBF-548E188D88A5Q43225805-FF2E8A34-8CBC-40D4-A5F5-1D5F15A4FD38Q43737933-63A0F63D-2922-47A0-A7C4-ACEA7C485A71Q43805095-4363E502-094F-4802-8CF4-2DB3366AC534Q45983590-3F1BFAE5-7807-4580-85AB-47D5C54D7CB9Q48267411-EB21F9FA-27EB-4AD7-B9CB-F95205D79419Q48361661-9AD8EF8D-20CD-42B1-B184-DDA1A276F367
P2860
Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Diagnostic and prognostic eval ...... mple of the general population
@ast
Diagnostic and prognostic eval ...... mple of the general population
@en
type
label
Diagnostic and prognostic eval ...... mple of the general population
@ast
Diagnostic and prognostic eval ...... mple of the general population
@en
prefLabel
Diagnostic and prognostic eval ...... mple of the general population
@ast
Diagnostic and prognostic eval ...... mple of the general population
@en
P2093
P2860
P921
P356
P1433
P1476
Diagnostic and prognostic eval ...... mple of the general population
@en
P2093
B A Groenning
F Pedersen
P R Hildebrandt
P2860
P304
P356
10.1136/HRT.2003.026021
P407
P577
2004-03-01T00:00:00Z